ELI LILLY & Co — Director's Dealing 2023

Aug 15, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2023-08-14

Reporting Person: LILLY ENDOWMENT INC (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-08-14	Common Stock	S	100500	$538.264	Disposed	100513310	Direct
2023-08-14	Common Stock	S	30918	$539.446	Disposed	100482392	Direct
2023-08-14	Common Stock	S	13571	$540.652	Disposed	100468821	Direct
2023-08-14	Common Stock	S	16933	$541.528	Disposed	100451888	Direct
2023-08-14	Common Stock	S	2856	$542.10	Disposed	100449032	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $538.00 to $538.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), and (5) to this Form 4.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $539.00 to $539.99, inclusive.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $540.00 to $540.995, inclusive.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $541.00 to $541.99, inclusive.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $542.00 to $542.24, inclusive.